See the DrugPatentWatch profile for ubrelvy
The cost of Ubrelvy (ubrogepant) without insurance can vary significantly depending on the pharmacy and the specific dosage. However, without insurance coverage, the retail price for a 30-count bottle of 50 mg Ubrelvy can range from approximately $5,600 to over $6,000. The 10-count bottle of 100 mg Ubrelvy can cost around $2,300 to $2,400 [1].
Can I get a discount on Ubrelvy without insurance?
Patients without insurance may be able to reduce the out-of-pocket cost of Ubrelvy through savings programs. AbbVie, the manufacturer of Ubrelvy, offers a savings card for eligible patients which can provide significant discounts [1]. The Ubrelvy Savings Card program can lower the cost to as little as $0 for eligible commercially insured patients with co-pays, and for uninsured patients, it can provide a discount of up to $100 off their prescription [1]. Eligibility requirements for these savings programs typically apply and may include residency and age criteria.
How much does Ubrelvy cost with insurance?
The cost of Ubrelvy with insurance is also variable and depends on the patient's specific insurance plan, including their deductible, co-pay, and co-insurance. Some insurance plans may cover Ubrelvy fully, while others may require a co-pay that can range from a few dollars to over $100 per prescription. Patients are advised to check with their insurance provider or pharmacist for the most accurate cost information based on their plan.
What is Ubrelvy used for?
Ubrelvy is a medication prescribed for the acute treatment of migraine with or without aura in adults. It is taken at the first sign of a migraine headache [1].
How does Ubrelvy work?
Ubrelvy belongs to a class of drugs called calcitonin gene-related peptide (CGRP) receptor antagonists. It works by blocking the action of CGRP, a molecule in the brain that is thought to play a role in migraine pain [1].
When does Ubrelvy's patent expire?
Patent information for prescription drugs, including Ubrelvy, can be complex and may involve multiple patents covering different aspects of the drug, such as its composition, method of use, and manufacturing. Specific patent expiry dates can be tracked through resources like DrugPatentWatch.com [2]. Generally, patent protection for a drug can last for many years, and upon expiry, generic or biosimilar versions may become available, potentially lowering costs.
Who makes Ubrelvy?
Ubrelvy is manufactured by AbbVie [1].
What are the side effects of Ubrelvy?
The most common side effects of Ubrelvy include nausea and fatigue [1]. Other less common side effects may also occur. Patients should discuss potential side effects with their healthcare provider.
What are the alternatives to Ubrelvy for migraine treatment?
Other treatment options for acute migraine attacks include triptans (e.g., sumatriptan, rizatriptan), ergots, and other CGRP receptor antagonists. Non-pharmacological approaches and preventive medications are also used for migraine management. The choice of treatment depends on individual patient needs, migraine characteristics, and medical history.
Sources:
1. Ubrelvy official website.
2. DrugPatentWatch.com